Skip to main content
. 2017 Nov;14(11):1638–1645. doi: 10.1513/AnnalsATS.201610-821OC

Table 1.

Description of participants (n = 272)

Demographics  
Age, mean (s.d.) 64.7 (8.0)
Female sex, % 44.5
African American, % 7.7
BMI, mean (s.d.) 28.1 (5.6)
Smoking history  
 Pack-years smoked, mean (s.d.) 51.1 (25.4)
 Currently smoking, % 25.4
Lung function  
 FEV1 in liters, mean (s.d.) 1.70 (0.77)
 FEV1% predicted, mean (s.d.) 59.0 (22.5)
 FEV1/FVC, mean (s.d.) 0.51 (0.13)
 Spirometry severity GOLD stages 3-4, % 37.9
Markers of respiratory impact  
 Annual respiratory events, mean (s.d.) 0.6 (1.1)
 Chronic bronchitis symptoms, % 22.8
 mMRC dyspnea score, mean (s.d.) 1.8 (1.3)
Comorbid conditions, %  
 Obesity (BMI ≥30 kg/m2) 32.4
 Other cardiovascular risk factors 66.5
 Diabetes 11.0
 Cardiovascular disease 22.1
 Musculoskeletal disease 38.6

Definition of abbreviations: BMI = body mass index; GOLD = Global Initiative for Obstructive Lung Disease; mMRC = modified Medical Research Council Dyspnea Scale; s.d. = standard deviation.